Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
Comparative antitumor activity of cytostatics dioxadet, cisplatin and their combination was studied in model of ascitic ovarian tumor in 38 female Wistar rats. Ascitic ovarian tumor was transplanted intraperitoneally at amount of 5 × 106 tumor cells per rat. Dioxadet andcisplatin were administered i...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-02-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/48 |
| _version_ | 1797875941630803968 |
|---|---|
| author | V. G. Bespalov A. A. Zhabin A. N. Stukov O. A. Beliaeva If. G. Murazov A. L. Semenov S. A. Kon’kov I. M. Krylova |
| author_facet | V. G. Bespalov A. A. Zhabin A. N. Stukov O. A. Beliaeva If. G. Murazov A. L. Semenov S. A. Kon’kov I. M. Krylova |
| author_sort | V. G. Bespalov |
| collection | DOAJ |
| description | Comparative antitumor activity of cytostatics dioxadet, cisplatin and their combination was studied in model of ascitic ovarian tumor in 38 female Wistar rats. Ascitic ovarian tumor was transplanted intraperitoneally at amount of 5 × 106 tumor cells per rat. Dioxadet andcisplatin were administered intraperitoneally at their single maximal tolerable doses 48 hours after the tumor transplantation: 1,5 and 4,0 mg/ kg b.w., respectively. Drug combination of dioxadet and cisplatin administered by the same way but at one half of maximal tolerable doses. Antitumor effects of the drugs were estimated by increasing life span of the animals. In control group without treatment the average life span was 16 ± 6,3 days. Dioxadet and cisplatin showed comparable antitumor activity increasing the average life span by 63,1 % and 48,1 %, correspondingly. Drugs combination showed synergistic effect increasing average life span by 107,5 % (p<0,05). Moreover, combinationof dioxadet and cisplatin are characterized by less toxicity compared with cisplatin applied in maximal tolerable dose. |
| first_indexed | 2024-04-10T01:55:29Z |
| format | Article |
| id | doaj.art-8b7a736a8b9746daa75929cb55b6b24e |
| institution | Directory Open Access Journal |
| issn | 1814-4861 2312-3168 |
| language | Russian |
| last_indexed | 2024-04-10T01:55:29Z |
| publishDate | 2016-02-01 |
| publisher | Russian Academy of Sciences, Tomsk National Research Medical Center |
| record_format | Article |
| series | Сибирский онкологический журнал |
| spelling | doaj.art-8b7a736a8b9746daa75929cb55b6b24e2023-03-13T09:05:46ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682016-02-0101424648Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumorV. G. Bespalov0A. A. Zhabin1A. N. Stukov2O. A. Beliaeva3If. G. Murazov4A. L. Semenov5S. A. Kon’kov6I. M. Krylova7ФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздравсоцразвития России, г. Санкт-ПетербургComparative antitumor activity of cytostatics dioxadet, cisplatin and their combination was studied in model of ascitic ovarian tumor in 38 female Wistar rats. Ascitic ovarian tumor was transplanted intraperitoneally at amount of 5 × 106 tumor cells per rat. Dioxadet andcisplatin were administered intraperitoneally at their single maximal tolerable doses 48 hours after the tumor transplantation: 1,5 and 4,0 mg/ kg b.w., respectively. Drug combination of dioxadet and cisplatin administered by the same way but at one half of maximal tolerable doses. Antitumor effects of the drugs were estimated by increasing life span of the animals. In control group without treatment the average life span was 16 ± 6,3 days. Dioxadet and cisplatin showed comparable antitumor activity increasing the average life span by 63,1 % and 48,1 %, correspondingly. Drugs combination showed synergistic effect increasing average life span by 107,5 % (p<0,05). Moreover, combinationof dioxadet and cisplatin are characterized by less toxicity compared with cisplatin applied in maximal tolerable dose.https://www.siboncoj.ru/jour/article/view/48рак яичникакомбинированная химиотерапиядиоксадэтцисплатин |
| spellingShingle | V. G. Bespalov A. A. Zhabin A. N. Stukov O. A. Beliaeva If. G. Murazov A. L. Semenov S. A. Kon’kov I. M. Krylova Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor Сибирский онкологический журнал рак яичника комбинированная химиотерапия диоксадэт цисплатин |
| title | Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor |
| title_full | Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor |
| title_fullStr | Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor |
| title_full_unstemmed | Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor |
| title_short | Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor |
| title_sort | synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor |
| topic | рак яичника комбинированная химиотерапия диоксадэт цисплатин |
| url | https://www.siboncoj.ru/jour/article/view/48 |
| work_keys_str_mv | AT vgbespalov synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT aazhabin synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT anstukov synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT oabeliaeva synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT ifgmurazov synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT alsemenov synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT sakonkov synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor AT imkrylova synergismofantitumoractionofdioxadetandcisplatininmodelofasciticovariantumor |